Cough Management in Patients with Aspiration Concerns

First-Line Approach for Cough Management

• The American Thoracic Society recommends starting with non-opioid treatments such as demulcents due to their low cost, some evidence of effect, and low side effect profile 1, 2
• Demulcents may be less effective in patients with profound cough, particularly when they contain subtherapeutic levels of active ingredients 3

Opioid Use for Cough Management

• Consider opioids when patients do not respond to demulcents and when cough is severe 4, 5
• Opioids have the most evidence in cough management, albeit of low methodological quality 5
• A stepwise approach is recommended, starting with other opioid derivatives (pholcodine, hydrocodone, dihydrocodeine) before using morphine 5

Dosing and Administration of Morphine

• The initial dose of morphine for cough is 5 mg oral morphine (single-dose trial) 4
• If effective, the dose can be increased to 5-10 mg slow-release morphine twice daily 4
• For patients already on morphine for other symptoms, consider increasing the dose by 20% 5

Alternative Approaches for Refractory Cases

• Consider peripherally-acting antitussives such as levodropropizine, moguisteine, or sodium cromoglycate if morphine is contraindicated or ineffective 4, 6
• Local anesthetics (nebulized lidocaine/bupivacaine) can be considered for opioid-resistant cough after careful aspiration risk assessment 4, 6
• Be aware that local anesthetics can also increase aspiration risk 6

Important Considerations

• Using morphine for cough without addressing underlying causes may mask important symptoms 6
• The decision to use morphine in patients with aspiration concerns requires careful risk-benefit assessment, appropriate dosing, and vigilant monitoring for respiratory depression 5